Apollo Hospitals Enterprise Limited secured approval from its equity shareholders, secured creditors, and unsecured creditors for the composite scheme of arrangement involving Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited. The meetings were convened on June 24, 2026, pursuant to the directions of the National Company Law Tribunal (NCLT), Chennai Bench. The scheme aims to demerge the identified business undertaking into Apollo Healthtech, amalgamate Apollo Healthco and Keimed with it, and subsequently list the resultant entity, thereby unlocking value and sharpening strategic focus.

Voting Results

The resolutions were passed with the requisite majority at all three meetings. Dr. K.S. Ravichandran, appointed by the NCLT, chaired the meetings, while Mr. S. Vedhavel, Advocate, served as the scrutinizer. Remote e-voting was conducted by National Securities Depository Limited from June 20, 2026, to June 23, 2026, followed by e-voting during the meetings.

Meeting Proceedings

The meetings were conducted through Video Conferencing (VC) and Other Audio-Visual Means (OAVM) in compliance with the Companies Act, 2013, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. For the equity shareholders' meeting, the quorum was initially not met, leading to a 30-minute adjournment before the meeting was called to order. Queries raised by unsecured creditors and equity shareholders were addressed by the management, including the Chief Financial Officer, while no clarifications were sought by secured creditors.

Governance and Future Steps

The composite scheme includes a governance framework for Apollo Healthtech, mandating a board composition of six independent directors. Ms. Shobana Kamineni is proposed to be appointed as the Executive Chairperson of Apollo Healthtech upon the sanction of the scheme by the NCLT. The voting results and the scrutinizer's report will be submitted to the stock exchanges and the NCLT within the prescribed timelines to facilitate the final approval process.

Apollo Hospitals Enterprise Limited has accepted the resignation of Mr. Dinesh Madhavan, President - Group Oncology and International, effective from the close of business hours on May 30, 2026. The company informed the stock exchanges that Mr. Madhavan, who was a designated senior management personnel, tendered his resignation, which the board has accepted. This development was disclosed to the Bombay Stock Exchange Ltd and the National Stock Exchange in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015.

Details of the Resignation

The cessation of Mr. Dinesh Madhavan's role marks a change in the senior management structure of Apollo Hospitals Enterprise Limited. The resignation was submitted following earlier discussions and mutually agreed dates, as indicated in the communication addressed to the management. The company has processed the resignation and relieved him of his duties effective immediately at the end of business hours on the specified date.

Regulatory Disclosure

The filing provided specific details regarding the change in senior management as required under the relevant circulars issued by the regulatory authority. The disclosure confirmed that the reason for the change was resignation and that no brief profile was necessary as this was not an appointment. The company also clarified that there were no specific disclosures required regarding relationships between directors in this instance.

Key Information

The communication was signed by S.M. Krishnan, Senior Vice President - Finance and Company Secretary, on behalf of Apollo Hospitals Enterprise Limited.